Clinical trial
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity
NCT00221442 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00221442 |
|---|---|
| Title | Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity |
| Official title | Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | Eisai Inc. Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Binge Eating Disorder Associated With Obesity |
| Intervention type | Drug |
| Interventions | Zonegran, sugar pill |
| Enrollment | 60 |
| Start date | Aug 1, 2005 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: